Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

92 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An immunomodulating peptide with potential to suppress tumour growth and autoimmunity.
Agrez M, Chandler C, Thurecht KJ, Fletcher NL, Liu F, Subramaniam G, Howard CB, Blyth B, Parker S, Turner D, Rzepecka J, Knox G, Nika A, Hall AM, Gooding H, Gallagher L. Agrez M, et al. Among authors: blyth b. Sci Rep. 2023 Nov 13;13(1):19741. doi: 10.1038/s41598-023-47229-y. Sci Rep. 2023. PMID: 37957274 Free PMC article.
An immunomodulating peptide to counteract solar radiation-induced immunosuppression and DNA damage.
Agrez M, Rybchyn MS, De Silva WGM, Mason RS, Chandler C, Piva TJ, Thurecht K, Fletcher N, Liu F, Subramaniam G, Howard CB, Blyth B, Parker S, Turner D, Rzepecka J, Knox G, Nika A, Hall A, Gooding H, Gallagher L. Agrez M, et al. Among authors: blyth b. Sci Rep. 2023 Jul 20;13(1):11702. doi: 10.1038/s41598-023-38890-4. Sci Rep. 2023. PMID: 37474630 Free PMC article.
Automated radiosynthesis of [89Zr]Zr-DFOSq-Durvalumab for imaging of PD-L1 expressing tumours in vivo.
Wichmann CW, Poniger S, Guo N, Roselt P, Rudd SE, Donnelly PS, Blyth B, Van Zuylekom J, Rigopoulos A, Burvenich IJG, Morandeau L, Mohamed S, Nowak AK, Hegi-Johnson F, MacManus M, Scott AM. Wichmann CW, et al. Among authors: blyth b. Nucl Med Biol. 2023 May-Jun;120-121:108351. doi: 10.1016/j.nucmedbio.2023.108351. Epub 2023 May 16. Nucl Med Biol. 2023. PMID: 37224789 Free article.
Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [161Tb]Tb-PSMA-I&T.
Buteau JP, Kostos L, Alipour R, Jackson P, McInstosh L, Emmerson B, Haskali MB, Xie J, Medhurst E, Ravi R, Gonzalez BD, Fettke H, Blyth B, Furic L, Owen K, Sandhu S, Murphy DG, Azad AA, Hofman MS. Buteau JP, et al. Among authors: blyth b. J Nucl Med. 2024 Aug 1;65(8):1231-1238. doi: 10.2967/jnumed.124.267650. J Nucl Med. 2024. PMID: 38991752
PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study.
Hegi-Johnson F, Rudd SE, Wichmann CW, Akhurst T, Roselt P, Sursock S, Trinh J, John T, Devereux L, Donnelly PS, Hicks RJ, Scott AM, Steinfort D, Fox S, Blyth B, Parakh S, Hanna GG, Callahan J, Burbury K, MacManus M. Hegi-Johnson F, et al. Among authors: blyth b. Int J Radiat Oncol Biol Phys. 2023 Nov 1;117(3):675-682. doi: 10.1016/j.ijrobp.2023.05.019. Epub 2023 Jul 3. Int J Radiat Oncol Biol Phys. 2023. PMID: 37406824 No abstract available.
92 results